Medical

Belgian company Arseus buys software company in Brazil

Belgian medical equipment company Arseus struck a deal to acquire a pharmaceutical software maker in Brazil called Alternate Technologies.


Salix Pharma agrees to acquire Santarus for USD2.6 billion

Salix Pharmaceuticals Ltd announced a definitive agreement to buy Santarus Inc for USD2.6 billion. Salix Pharmaceuticals Ltd agreed to purchase Santarus Inc for USD32 per share or USD2.

Top deals of the day - M&As

The following bids, mergers, acquisitions and disposals were reported on Thursday. The following bids, mergers, acquisitions and disposals were reported on Thursday.

Aerpio Therapeutics closes Series A funding round

Biopharmaceutical firm Aerpio Therapeutics Inc closes Series A funding round extension worth USD9 million.


Latest News

Sources told Reuters that Chemtrade Logistics Inc is already in talks to buy General Chemical Corp, a company owned by private equity firm American Securities.
The following bids, mergers, acquisitions and disposals were reported on Wednesday The following bids, mergers, acquisitions and disposals were reported on Wednesday:Germany's Siemens agreed to sell the bulk of its water technologies business to private equity group AEA Investors for 640 million euros ($862 million).
Paul Singer's Elliott Management Corp increased its shareholdings in German drug distribution firm Celesio AG.
Sulaiman Al-Habib (HMG) and Almana General Hospitals have engaged the services of separate banks to assist in its IPO listing.
PurThread Technologies raised USD7 million for its latest equity funding round. Renowned textile firm PurThread Technologies recently announced the closure of its latest equity funding round with pledges amounting to USD7 million.
General Electric Healthcare India would be creating cost effective equipment to address global demands.
Avante Mezzanine Partners helped finance TechDevice Holdings' acquisition of AdvancedCath Technologies with debt and equity.
The following bids, mergers, acquisitions and disposals were reported on Tuesday. The following bids, mergers, acquisitions and disposals were reported on Tuesday.
Midatech's unique biocompatible gold-nanoparticles raised GBP10 million from investors. One of the global leaders in nanomedicine design, synthesis and manufacturing, Midatech Ltd, announced the completion of the issuance of its new equity.
Edmond de Rothschild raises EUR192 million or USD250 million for its BioDiscovery 4 fund. The Edmond de Rothschild Investment Partners have announced the closure of its BioDiscovery 4 Venture capital fund for European life science companies.
  15 16 17 18 19 20 21  
Real Time Analytics